Click on Guy Sauvageau’s interview last october on why should we target RUNX1 in AML treatment.
Author Archive for: muriel
About Muriel Draoui
This author has yet to write their bio.Meanwhile lets just say that we are proud Muriel Draoui contributed a whooping 7 entries.
Entries by Muriel Draoui
Vincent will bring his expertise in single cell sequencing analysis! Positions are available in his laboratory which opened on October 2019 at CHU Sainte-Justine Research Center. Please visit www.lavalleelab.com for more details.
Cost-effectiveness analysis of a HMGA2 prognostic test for acute myeloid leukemia in a Canadian setting is now available in Applied Health Economics and Health Policy.
H3K27M/I mutations promote context-dependent transformation in acute myeloid leukemia with RUNX1 alterations is now published in Blood.